Article
Rare variant screening and burden analysis of PLXNA1 in Parkinson's disease.
European journal of neurology - 1 Dec 2022
Li Chunyu, Lin Junyu, Jiang Qirui, Shang Huifang
Abstract excerpt
BACKGROUND AND PURPOSE: Recently, p.Glu1121Ter in PLXNA1 was identified as a potential cause of parkinsonism. However, no further replication has been conducted in a wider range of Parkinson's disease (PD) cohorts. We aimed to evaluate the genetic role of PLXNA1 in PD. METHODS: We systematically analyzed the rare protein-coding variants (minor allele frequency [MAF] < 0.01) in 1080 patients and 1051 healthy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
